The role of molecular diagnosis in anaphylactic patients with dual or triple-sensitization to Hymenoptera venoms.

Bee sting Bee venom allergy Honey bee Hymenoptera IgE Molecular diagnosis Paper wasp Sensitization Yellow jacket

Journal

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313

Informations de publication

Date de publication:
23 Mar 2024
Historique:
received: 25 11 2023
accepted: 29 02 2024
medline: 24 3 2024
pubmed: 24 3 2024
entrez: 24 3 2024
Statut: epublish

Résumé

The poly-sensitization to Hymenoptera venom makes it difficult to select genuine allergens for immunotherapy and increases patients' costs. The objective of this study was to determine the culprit allergen in dual or triple-sensitized patients to three Hymenoptera venoms through molecular diagnosis and evaluating the results of incorporating the molecular diagnosis with skin tests. Thirty-two patients with anaphylactic reactions and dual or triple-sensitization to Hymenoptera venoms in skin tests entered this study. IgE-sensitization to whole extracts and molecules of Apis mellifera (Api m), Vespula vulgaris (Ves v), and Polistes dominulus (Pol d) was evaluated utilizing ALEX or ImmunoCAP. Twenty-nine patients (90.6%) were male. IgE-sensitization to at least one of the allergenic molecules related to Apis mellifera, Vespula vulgaris, and Polistes dominulus was seen in 59.4, 53.1, and 21.9%, respectively. Among 32 patients, 14 (43.8) and 8 (25%), were mono-sensitized to Api m and Ves v components in ALEX, respectively. Double sensitization to Hymenoptera was identified in 18.8% of patients in ALEX. Api m 1+/Api m 2-/Api m 10- and Ves v 1+/Ves v 5+ demonstrated the most prevalent sensitizations patterns in our patients. The molecular diagnosis of IgE-sensitization to Hymenoptera venoms can be valuable, especially in patients who show dual or triple-sensitization in skin tests, as the ALEX results revealed mono and double-sensitization to Hymenoptera venoms in 22 and 6 patients, respectively. Regarding the high cost and adverse reactions of venom immunotherapy, especially for two or three venoms, incorporating the molecular diagnosis alongside skin tests for accurate diagnosis of the culprit venom could help decrease costs for patients.

Sections du résumé

BACKGROUND BACKGROUND
The poly-sensitization to Hymenoptera venom makes it difficult to select genuine allergens for immunotherapy and increases patients' costs. The objective of this study was to determine the culprit allergen in dual or triple-sensitized patients to three Hymenoptera venoms through molecular diagnosis and evaluating the results of incorporating the molecular diagnosis with skin tests.
METHODS METHODS
Thirty-two patients with anaphylactic reactions and dual or triple-sensitization to Hymenoptera venoms in skin tests entered this study. IgE-sensitization to whole extracts and molecules of Apis mellifera (Api m), Vespula vulgaris (Ves v), and Polistes dominulus (Pol d) was evaluated utilizing ALEX or ImmunoCAP.
RESULTS RESULTS
Twenty-nine patients (90.6%) were male. IgE-sensitization to at least one of the allergenic molecules related to Apis mellifera, Vespula vulgaris, and Polistes dominulus was seen in 59.4, 53.1, and 21.9%, respectively. Among 32 patients, 14 (43.8) and 8 (25%), were mono-sensitized to Api m and Ves v components in ALEX, respectively. Double sensitization to Hymenoptera was identified in 18.8% of patients in ALEX. Api m 1+/Api m 2-/Api m 10- and Ves v 1+/Ves v 5+ demonstrated the most prevalent sensitizations patterns in our patients.
CONCLUSIONS CONCLUSIONS
The molecular diagnosis of IgE-sensitization to Hymenoptera venoms can be valuable, especially in patients who show dual or triple-sensitization in skin tests, as the ALEX results revealed mono and double-sensitization to Hymenoptera venoms in 22 and 6 patients, respectively. Regarding the high cost and adverse reactions of venom immunotherapy, especially for two or three venoms, incorporating the molecular diagnosis alongside skin tests for accurate diagnosis of the culprit venom could help decrease costs for patients.

Identifiants

pubmed: 38521942
doi: 10.1186/s13223-024-00885-9
pii: 10.1186/s13223-024-00885-9
doi:

Types de publication

Journal Article

Langues

eng

Pagination

22

Informations de copyright

© 2024. The Author(s).

Références

Peters RS, Krogmann L, Mayer C, Donath A, Gunkel S, Meusemann K, et al. Evolutionary history of the hymenoptera. Curr Biol CB. 2017;27(7):1013–8. https://doi.org/10.1016/j.cub.2017.01.027 .
doi: 10.1016/j.cub.2017.01.027 pubmed: 28343967
Bilò MB, Tontini C, Martini M, Corsi A, Agolini S, Antonicelli L. Clinical aspects of hymenoptera venom allergy and venom immunotherapy. Eur Ann Allergy Clin Immunol. 2019;51(6):244–58. https://doi.org/10.23822/EurAnnACI.1764-1489.113 .
doi: 10.23822/EurAnnACI.1764-1489.113 pubmed: 31594296
Sahiner UM, Durham SR. Hymenoptera venom allergy: how does venom immunotherapy prevent anaphylaxis from bee and wasp stings? Front Immunol. 2019;10:1959. https://doi.org/10.3389/fimmu.2019.01959 .
doi: 10.3389/fimmu.2019.01959 pubmed: 31497015 pmcid: 6712168
Schiener M, Graessel A, Ollert M, Schmidt-Weber CB, Blank S. Allergen-specific immunotherapy of Hymenoptera venom allergy—also a matter of diagnosis. Hum Vaccin Immunother. 2017;13(10):2467–81. https://doi.org/10.1080/21645515.2017.1334745 .
doi: 10.1080/21645515.2017.1334745 pubmed: 28604163 pmcid: 5647953
Perez-Riverol A, Campos Pereira FD, Musacchio Lasa A, Romani Fernandes LG, Santos-Pinto JR, Justo-Jacomini DL, et al. Molecular cloning, expression and IgE-immunoreactivity of phospholipase A1, a major allergen from Polybia paulista (Hymenoptera: Vespidae) venom. Toxicon Off J Int Soc Toxinol. 2016;124:44–52. https://doi.org/10.1016/j.toxicon.2016.11.006 .
doi: 10.1016/j.toxicon.2016.11.006
Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, et al. EAACI molecular allergology user’s guide. Pediatr Allergy Immunol. 2016;27(S23):1–250. https://doi.org/10.1111/pai.12563 .
doi: 10.1111/pai.12563 pubmed: 27288833
Antolín-Amérigo D, Ruiz-León B, Boni E, Alfaya-Arias T, Álvarez-Mon M, Barbarroja-Escudero J, et al. Component-resolved diagnosis in hymenoptera allergy. Allergol Immunopathol. 2018;46(3):253–62. https://doi.org/10.1016/j.aller.2017.05.003 .
doi: 10.1016/j.aller.2017.05.003
Perez-Riverol A, Palma MS, Jakob T. Current challenges in molecular diagnostics of insect venom allergy. Allergo J Int. 2020;29(3):79–91. https://doi.org/10.1007/s40629-020-00119-5 .
doi: 10.1007/s40629-020-00119-5
Heffler E, Puggioni F, Peveri S, Montagni M, Canonica GW, Melioli G. Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis. World Allergy Organ J. 2018;11(1):7. https://doi.org/10.1186/s40413-018-0186-3 .
doi: 10.1186/s40413-018-0186-3 pubmed: 29743964 pmcid: 5918992
Available from: http://www.allergen.org .
Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, et al. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy. 2011;41(9):1201–20. https://doi.org/10.1111/j.1365-2222.2011.03788.x .
doi: 10.1111/j.1365-2222.2011.03788.x pubmed: 21848758
Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organiz J. 2011;4(2):13–37. https://doi.org/10.1097/WOX.0b013e318211496c .
doi: 10.1097/WOX.0b013e318211496c
Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res. 1966;3(4):331–3. https://doi.org/10.3109/02770906609106941 .
doi: 10.3109/02770906609106941 pubmed: 4380730
Burks AW, Holgate ST, O’Hehir RE, Bacharier LB, Broide DH, Hershey GK, et al. Middleton’s allergy E-Book: principles and practice. 9th ed. Amsterdam: Elsevier Health Sciences; 2020.
Quirt JA, Wen X, Kim J, Herrero AJ, Kim HL. Venom allergy testing: is a graded approach necessary? Ann Allergy Asthma Immunol. 2016;116(1):49–51. https://doi.org/10.1016/j.anai.2015.10.007 .
doi: 10.1016/j.anai.2015.10.007 pubmed: 26520578
Bemanian MH, Ghelichi-Ghojogh M, Aghapour SA. A new approach to eliminate hymenoptera venom grading sensitization test in the North Iran: cross-sectional study. Med J Islam Repub Iran. 2024;38(1):6–9. https://doi.org/10.47176/mjiri.38.2 .
doi: 10.47176/mjiri.38.2
Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014;15(1):293. https://doi.org/10.1186/1471-2105-15-293 .
doi: 10.1186/1471-2105-15-293 pubmed: 25176396 pmcid: 4261873
Bemanian MH, Arshi S, Nabavi M, Fallahpour M, Aarabi M, Karbasi M, et al. Anaphylactic reaction to a bee's sting in rural areas of Gorgan City: the first epidemiological study of anaphylaxis due to hymenoptera in Iran. 2019.
Shin YS, Liu JN, Hur G-Y, Hwang E-K, Nam YH, Jin HJ, et al. Clinical features and the diagnostic value of component allergen-specific IgE in hymenoptera venom allergy. Allergy Asthma Immunol Res. 2012;4(5):284–9. https://doi.org/10.4168/aair.2012.4.5.284 .
doi: 10.4168/aair.2012.4.5.284 pubmed: 22950034 pmcid: 3423602
Hirata H, Sato K, Ogasawara T, Funakoshi T, Shima D, Tatewaki M, et al. Sensitization to Api m 1, Api m 2, and Api m 4 in Japanese beekeepers who had experienced systemic reactions to honeybee stings. Allergol Int. 2019;68(2):261–3. https://doi.org/10.1016/j.alit.2018.08.008 .
doi: 10.1016/j.alit.2018.08.008 pubmed: 30279045
Gelincik A, İşsever H, Unal D, Işık E, Demirturk M, Gül H, et al. The prevalence of Hymenoptera venom allergy in adults: the results of a very crowded city in Euroasia. Allergol Int. 2015;64(1):35–40. https://doi.org/10.1016/j.alit.2014.10.001 .
doi: 10.1016/j.alit.2014.10.001 pubmed: 25605527
Blank S, Haemmerle S, Jaeger T, Russkamp D, Ring J, Schmidt-Weber CB, et al. Prevalence of Hymenoptera venom allergy and sensitization in the population-representative German KORA cohort. Allergo J Int. 2019;28(6):183–91. https://doi.org/10.1007/s40629-018-0089-4 .
doi: 10.1007/s40629-018-0089-4
Ruëff F. Natural history and long-term follow-up of Hymenoptera allergy. Curr Opin Allergy Clin Immunol. 2020;20(5):445–51. https://doi.org/10.1097/aci.0000000000000671 .
doi: 10.1097/aci.0000000000000671 pubmed: 32739977
ShokouhiShoormasti R, Pourpak Z, Fazlollahi MR, Kazemnejad A, Nadali F, Ebadi Z, et al. The prevalence of allergic rhinitis, allergic conjunctivitis, atopic dermatitis and asthma among adults of Tehran. Iran J Public Health. 2018;47(11):1749–55.
Yavuz ST, Sahiner UM, Buyuktiryaki B, Soyer OU, Sackesen C, Sekerel BE, et al. Clinical features of children with venom allergy and risk factors for severe systemic reactions. Int Arch Allergy Immunol. 2013;160(3):313–21. https://doi.org/10.1159/000341666 .
doi: 10.1159/000341666 pubmed: 23095437
Blank S, Haemmerle S, Jaeger T, Russkamp D, Ring J, Schmidt-Weber CB, et al. Prevalence of Hymenoptera venom allergy and sensitization in the population-representative German KORA cohort. Allergo J. 2019;28(6):42–51. https://doi.org/10.1007/s15007-019-1916-8 .
doi: 10.1007/s15007-019-1916-8
Müller U, Schmid-Grendelmeier P, Hausmann O, Helbling A. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy. Allergy. 2012;67(8):1069–73. https://doi.org/10.1111/j.1398-9995.2012.02847.x .
doi: 10.1111/j.1398-9995.2012.02847.x pubmed: 22676144
Bemanian MH, Arshi S, Nabavi M, Fallahpour M, Aarabi M, Karbasi M, et al. Anaphylactic reaction to bee stings in the rural areas of Gorgan City: Iran’s first epidemiological study of hymenoptera-induced anaphylaxis. J Pediatr Rev. 2019;7(4):239–48. https://doi.org/10.32598/jpr.7.4.239 .
doi: 10.32598/jpr.7.4.239
Plunkett G, Jacobson RS, Golden DBK. Hymenoptera venoms used to produce allergen extracts. Ann Allergy Asthma Immunol. 2017;118(6):649–54. https://doi.org/10.1016/j.anai.2016.05.027 .
doi: 10.1016/j.anai.2016.05.027 pubmed: 28583258
Köhler J, Blank S, Müller S, Bantleon F, Frick M, Huss-Marp J, et al. Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol. 2014;133(5):1383–9. https://doi.org/10.1016/j.jaci.2013.10.060 .
doi: 10.1016/j.jaci.2013.10.060 pubmed: 24440283
Bilò MB, Ollert M, Blank S. The role of component-resolved diagnosis in Hymenoptera venom allergy. Curr Opin Allergy Clin Immunol. 2019;19(6):614–22. https://doi.org/10.1097/aci.0000000000000574 .
doi: 10.1097/aci.0000000000000574 pubmed: 31343438
Eiken P, Mosbech H, Jacobsen L, Larsen P, Scharling B, Svendsen UG, et al. Comparison between two different assays for measurements of allergen-specific IgE and skin prick test in the diagnosis of insect venom allergy. Allergy. 1992;47(5):495–7. https://doi.org/10.1111/j.1398-9995.1992.tb00671.x .
doi: 10.1111/j.1398-9995.1992.tb00671.x pubmed: 1485652
Vos B, Köhler J, Müller S, Stretz E, Ruëff F, Jakob T. Spiking venom with rVes v 5 improves sensitivity of IgE detection in patients with allergy to Vespula venom. J Allergy Clin Immunol. 2013;131(4):1225–7. https://doi.org/10.1016/j.jaci.2012.07.041 .
doi: 10.1016/j.jaci.2012.07.041 pubmed: 23006544
Ono T, Yoshida M, Nakazono N. Hymenoptera stings and serum venom-specific IgE in Japanese Pest-control operators. Environ Health Prev Med. 1998;2(4):172–6. https://doi.org/10.1007/bf02931697 .
doi: 10.1007/bf02931697 pubmed: 21432537 pmcid: 2723355
Sturm GJ, Biló MB, Bonadonna P, Hemmer W, Caruso B, Bokanovic D, et al. Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe. J Allergy Clin Immunol. 2012;130(3):817. https://doi.org/10.1016/j.jaci.2012.05.047 .
doi: 10.1016/j.jaci.2012.05.047 pubmed: 22795371
Gawlik R, Marcak M, Bożek A. Importance of wasp and honey bee recombinant allergens in the diagnosis of hymenoptera venom anaphylaxis. Alergoprofil. 2019;15(1):11–5.
doi: 10.24292/01.AP.151090119
Jakob T, Müller U, Helbling A, Spillner E. Component resolved diagnostics for hymenoptera venom allergy. Curr Opin Allergy Clin Immunol. 2017;17(5):363–72. https://doi.org/10.1097/ACI.0000000000000390 .
doi: 10.1097/ACI.0000000000000390 pubmed: 28759475 pmcid: 5588610
Reisman RE, Wypych J, Arbesman CE. Stinging insect allergy: detection and clinical significance of venom IgE antibodies. J Allergy Clin Immunol. 1975;56(6):443–9. https://doi.org/10.1016/0091-6749(75)90062-7 .
doi: 10.1016/0091-6749(75)90062-7 pubmed: 1206184
Šelb J, BidovecStojković U, Bajrović N, Kopač P, Eržen R, Zidarn M, et al. Limited ability of recombinant Hymenoptera venom allergens to resolve IgE double sensitization. J Allergy Clin Immunol Pract. 2018;6(6):2118–20. https://doi.org/10.1016/j.jaip.2018.04.045 .
doi: 10.1016/j.jaip.2018.04.045 pubmed: 29802909
Ludman SW, Boyle RJ. Stinging insect allergy: current perspectives on venom immunotherapy. J Asthma Allergy. 2015;8:75–86. https://doi.org/10.2147/JAA.S62288 .
doi: 10.2147/JAA.S62288 pubmed: 26229493 pmcid: 4517515
Jovanovic D, Peric-Popadic A, Andrejevic S, Stojanovic M, Bonaci-Nikolic B. The Diagnostic Importance of Recombinant Allergen IgE Testing in Patients with Hymenoptera Venom Allergy: Comparison of Two Methods. Iran J Allergy Asthma Immunol. 2021; 7;20(4):413–422. https://doi.org/10.18502/ijaai.v20i4.6951 .

Auteurs

Mohammad Hassan Bemanian (MH)

Department of Allergy and Clinical Immunology, Rasool-E-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Raheleh Shokouhi Shoormasti (R)

Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.

Saba Arshi (S)

Department of Allergy and Clinical Immunology, Rasool-E-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Mahsa Jafari (M)

Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.

Sima Shokri (S)

Department of Allergy and Clinical Immunology, Rasool-E-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Morteza Fallahpour (M)

Department of Allergy and Clinical Immunology, Rasool-E-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Mohammad Nabavi (M)

Department of Allergy and Clinical Immunology, Rasool-E-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Fatemeh Zaremehrjardi (F)

Department of Allergy and Clinical Immunology, Rasool-E-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. dr.fzare217@gmail.com.
Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran. dr.fzare217@gmail.com.

Classifications MeSH